needle biopsy

PROCEDURE16 trials

Sponsors

University of Washington, University of California, San Francisco, NCIC Clinical Trials Group, University of Nebraska, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions

Adenocarcinoma of the LungAdenocarcinoma of the ProstateBRCA1 MutationBreast BiopsyBreast CancerEstrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerHER2-positive Breast Cancer

Phase 1

C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer

CompletedNCT00804245

Wake Forest University Health SciencesProstate Cancer

Start: 2008-08-31End: 2013-08-31Updated: 2018-07-03

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

WithdrawnNCT00903214

Barbara Ann Karmanos Cancer InstituteBreast Cancer

Start: 2009-05-31End: 2011-06-30Updated: 2013-04-29

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

CompletedNCT01259089

Northwestern UniversityAdenocarcinoma of the Lung, Non-small Cell Lung Cancer

Start: 2011-04-27End: 2014-09-29Updated: 2019-09-11

Phase 2

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

CompletedNCT00194779

University of WashingtonEstrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer +6

Start: 2003-10-31End: 2011-06-30Updated: 2018-03-12

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

CompletedNCT00466752

University of WashingtonAdenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage II Prostate Cancer

Start: 2006-12-31End: 2011-07-01Updated: 2017-11-22

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

CompletedNCT00482755

NCIC Clinical Trials GroupBreast Cancer

Start: 2009-04-08End: 2011-01-18Updated: 2024-02-12

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

TerminatedNCT00665457

University of NebraskaBreast Cancer

Start: 2004-04-15End: 2009-07-31Updated: 2023-09-13

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

CompletedNCT00673569

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLung Cancer

Start: 2006-09-30Target: 40Updated: 2010-08-09

Unknown Phase

Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules

CompletedNCT00316823

University of California, San FranciscoHead and Neck Cancer

Start: 2005-07-31Target: 400Updated: 2014-02-24

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

CompletedNCT00362973

University of WashingtonBreast Cancer

Start: 2006-05-31Updated: 2016-12-28

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

TerminatedNCT00700778

Fox Chase Cancer CenterBRCA1 Mutation, Breast Cancer

Start: 2008-07-31End: 2014-03-31Updated: 2021-01-25

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

TerminatedNCT00813878

City of Hope Medical CenterBreast Cancer

Start: 2001-07-31End: 2012-09-30Updated: 2017-10-13

Laser Spectroscopy of Breast Tissue Through a Needle Device

CompletedNCT00918788

Case Comprehensive Cancer CenterBreast Cancer

Start: 2008-04-30End: 2013-02-28Updated: 2013-08-22

14 g vs. 16 g in Breast Biopsy

CompletedNCT03212040

University Hospital TuebingenBreast Biopsy

Start: 2011-12-05End: 2018-06-07Updated: 2024-07-22

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

RecruitingNCT05229341

City of Hope Medical CenterThyroid Gland Carcinoma

Start: 2021-10-22End: 2026-10-22Target: 1450Updated: 2026-02-23

MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology

RecruitingNCT06409949

University of NebraskaPeripheral Arterial Disease

Start: 2023-06-01End: 2027-06-01Target: 60Updated: 2026-02-24